Description
The abstract explicitly states that mechanisms involved in congenital DM1 (CDM) are not clearly described, despite RNA foci being present during development. This knowledge gap is critical since CDM is the most severe form of the disease and likely requires distinct therapeutic approaches.
Gap type: open_question Source paper: Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development. (None, None, PMID:26339785)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:27.025580+00:00”, “resolution_summary”: “Resolved by hypothesis h-3a4f2027: Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Targeting. Supporting evidence includes debate sess_SDA-2026-04-15-gap-pubmed-20260410-100455-ff18091d.”, “match_counts”: {“hypothesis_matches”: 1, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-3a4f2027”, “title”: “Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Targeting”, “score”: 0.351, “reason”: “23 token overlaps; entity overlap: dmpk, rna”, “analysis_id”: “SDA-2026-04-03-gap-crispr-neurodegeneration-20260402”, “target_gene”: “HTT, DMPK, repeat-containing transcripts”, “target_pathway”: “CRISPR-Cas13 RNA targeting / trinucleotide repeat expansion”, “disease”: “neurodegeneration”, “composite_score”: 0.6127830000000001, “confidence_score”: 0.5, “status”: “proposed”, “pubmed_evidence_ids”: [“29962047”, “31601939”, “33649586”, “34261473”, “34731344”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-15-gap-pubmed-20260410-100455-ff18091d”, “title”: “The abstract challenges the rationale for using microtubule-stabilizing drugs in tau diseases, since tau appears to destabilize rather than stabilize microtubules. This paradigm shift has immediate implications for therapeutic development but requires validation.\n\nGap type: open_question\nSource paper: Tau: It’s Not What You Think. (2019, Trends Cell Biol, PMID:30929793)”, “score”: 0.445, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260410-100455-ff18091d”, “quality_score”: 0.68, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “title”: “The abstract explicitly questions whether AD’s hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets but remains unresolved despite evidence that β-amyloid affects cholinergic receptors.\n\nGap type: open_question\nSource paper: The cholinergic system in aging and neuronal degeneration. (2011, Behavioural brain research, PMID:21145918)”, “score”: 0.426, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260411-082446-2c1c9e2d”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-12-20260411-082446-2c1c9e2d_20260412-210950”, “title”: “The abstract explicitly questions whether AD’s hallmark pathologies induce cholinergic dysfunction or vice versa. This fundamental causality question is critical for determining therapeutic targets but remains unresolved despite evidence that β-amyloid affects cholinergic receptors.\n\nGap type: open_question\nSource paper: The cholinergic system in aging and neuronal degeneration. (2011, Behavioural brain research, PMID:21145918)”, “score”: 0.426, “reason”: “12 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-12-20260411-082446-2c1c9e2d”, “quality_score”: 0.79, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “title”: “The abstract reveals FUS has a chaperone-like function regulating TAZ condensate dynamics, but doesn’t address how FUS mutations in ALS/FTD might disrupt this function. This gap is critical since FUS mutations cause neurodegeneration, yet this newly discovered role in transcriptional regulation remains unexplored in disease context.\n\nGap type: open_question\nSource paper: A chaperone-like function of FUS ensures TAZ condensate dynamics and transcriptional activation. (None, None, PMID:38172614)”, “score”: 0.387, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2_task_9aae8fc5”, “title”: “While the abstract identifies AQP4 as a ‘potential and promising target’ and mentions it could provide ‘new therapeutic alternatives,’ the specific approaches for therapeutic modulation of AQP4 function are not defined. This represents a critical translational gap for moving from mechanistic understanding to clinical intervention.\n\nGap type: open_question\nSource paper: Aquaporin-4 in glymphatic system, and its implication for central nervous system disorders. (2023, Neurobiol Dis, PMID:36796590)”, “score”: 0.387, “reason”: “10 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-041445-7e1dc0b2”, “quality_score”: 0.76, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}